Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SWAV

Shockwave Medical (SWAV) Stock Price, News & Analysis

Shockwave Medical logo

About Shockwave Medical Stock (NASDAQ:SWAV)

Key Stats

Today's Range
$334.75
$334.75
50-Day Range
$328.87
$334.83
52-Week Range
$157.00
$334.90
Volume
N/A
Average Volume
968,088 shs
Market Capitalization
$12.57 billion
P/E Ratio
78.21
Dividend Yield
N/A
Price Target
$320.50
Consensus Rating
Hold

Company Overview

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Shockwave Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
44th Percentile Overall Score

SWAV MarketRank™: 

Shockwave Medical scored higher than 44% of companies evaluated by MarketBeat, and ranked 636th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Shockwave Medical has received a consensus rating of Hold. The company's average rating score is 2.10, and is based on 1 buy rating, 9 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Shockwave Medical has received no research coverage in the past 90 days.

  • Read more about Shockwave Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Shockwave Medical are expected to grow by 21.98% in the coming year, from $5.05 to $6.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Shockwave Medical is 78.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.72.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Shockwave Medical is 78.21, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 86.97.

  • Price to Earnings Growth Ratio

    Shockwave Medical has a PEG Ratio of 2.43. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Shockwave Medical has a P/B Ratio of 16.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for SWAV.
  • Dividend Yield

    Shockwave Medical does not currently pay a dividend.

  • Dividend Growth

    Shockwave Medical does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for SWAV.
    • Insider Buying vs. Insider Selling

      In the past three months, Shockwave Medical insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.40% of the stock of Shockwave Medical is held by insiders.

    • Percentage Held by Institutions

      95.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about Shockwave Medical's insider trading history.
    Receive SWAV Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

    SWAV Stock News Headlines

    We recommended Palantir in 2021, now we’re recommending this...
    My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
    GRPM: Why This Mid-Cap GARP ETF Deserves An Upgrade
    See More Headlines

    SWAV Stock Analysis - Frequently Asked Questions

    Shockwave Medical, Inc. (NASDAQ:SWAV) released its earnings results on Monday, May, 6th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $0.99 by $0.45. The business's quarterly revenue was up 35.8% compared to the same quarter last year.

    Shockwave Medical (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Shockwave Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Arista Networks (ANET), ServiceNow (NOW) and CrowdStrike (CRWD).

    Company Calendar

    Last Earnings
    5/06/2024
    Today
    12/23/2024
    Fiscal Year End
    12/31/2024

    Industry, Sector and Symbol

    Sector
    Medical
    Industry
    Surgical & medical instruments
    Sub-Industry
    N/A
    Current Symbol
    NASDAQ:SWAV
    Fax
    N/A
    Employees
    1,468
    Year Founded
    N/A

    Price Target and Rating

    Average Stock Price Target
    $320.50
    High Stock Price Target
    $368.00
    Low Stock Price Target
    $210.00
    Potential Upside/Downside
    -4.3%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.10
    Research Coverage
    10 Analysts

    Profitability

    Net Income
    $147.28 million
    Pretax Margin
    23.29%

    Debt

    Sales & Book Value

    Annual Sales
    $787.97 million
    Cash Flow
    $4.31 per share
    Book Value
    $20.02 per share

    Miscellaneous

    Free Float
    36,268,000
    Market Cap
    $12.57 billion
    Optionable
    Optionable
    Beta
    0.88
    2025 Gold Forecast: A Perfect Storm for Demand Cover

    Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

    Get This Free Report

    This page (NASDAQ:SWAV) was last updated on 12/23/2024 by MarketBeat.com Staff
    From Our Partners